The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.515%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 383.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MREL Resolution Group Banco Santander

28 Nov 2019 18:17

RNS Number : 0690V
Banco Santander S.A.
28 November 2019
 

 

 

 

Banco Santander, S.A. ("Santander"), pursuant to the Securities Market Law, hereby announces the following:

 

INSIDE INFORMATION

 

The Bank of Spain has formally notified the binding minimum requirement for eligible liabilities and own funds ("MREL"), both total and subordinated, for the resolution group headed by Santander[1] (the "Resolution Group"), as determined by the Single Resolution Board ("SRB"). On 1 January 2020, this requirement will replace the one that was applicable previously and that was announced through a material fact on 24 May 2018 (CNMV registration number 266090).

The MREL requirement has been set in terms of the Resolution Group's total liabilities and own funds ("TLOF"). It consists of a requirement for eligible liabilities as a percentage of TLOF ("Total MREL") and, within this, a requirement for eligible liabilities with subordination as a percentage of TLOF ("Subordinated MREL").

For ease of understanding, the table below includes an equivalent percentage in risk-weighted assets and an equivalent amount using data as at 31 December 2017 (the date used by the SRB for calibrating the MREL requirement). It also includes, for comparison purposes, the Total MREL requirement announced in the previous material fact, and the equivalent percentage and amount for this requirement:

 

Requirement in terms of total liabilities and own funds

Equivalent percentage in risk-weighted assets at 31/12/17

Equivalent amount

(EUR million) at 31/12/17

Total MREL

Communicated on

28/11/19

16.81%

28.60%

108,631.80

Subordinated MREL[2]

Communicated on

28/11/19

11.48%

19.53%

74,187.57

 

 

 

 

Requirement in terms of total liabilities and own funds

Equivalent percentage in risk-weighted assets at 31/12/16

Equivalent amount

(EUR million) at 31/12/16

MREL previously announced on 24/05/18

22.90%

24.35%

114,482.84

 

The variation in the MREL requirement with respect to 2018 is accounted for mainly by two factors: (i) a change in the scope of consolidation of the Resolution Group, which now includes new companies; and (ii) a modification in the calculation of capital consumption due to equity risk; changes that have led to a reduction in the risk-weighted assets of the Resolution Group.

According to our estimates, the Resolution Group complies with the new MREL requirement and the subordination requirement. Future requirements are subject to ongoing review by the resolution authority.

 

 

Boadilla del Monte, Madrid, 28 November 2019

 

[1]The Resolution Group comprises Banco Santander, S.A. and the entities that belong to the same European resolution group, mainly the entities of the sub-group headed by Santander Consumer Finance. S.A.

At 31 December 2017, the Resolution Group had risk-weighted assets amounting to EUR 379,835 million and TLOF amounting to EUR 646,233 million.

[2]The SRB considers that the subordination requirement can be covered by non-subordinated instruments in an amount equivalent to 2.5% of risk-weighted assets, 1.47% in terms of TLOF, having considered the absence of material adverse impact on resolvability. If this allowance were taken into account, the requirement that would have to be covered by subordinated instruments would be 10.01% in terms of TLOF and 17.03% in terms of RWAs, using data as of December 2017 as a reference.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMMMZMRRDGLZM
Date   Source Headline
24th Apr 20237:00 amRNSEnd of the Programme & 19-21 April Transactions
19th Apr 202311:22 amRNSBuyback programme: transactions 12 - 18 April
18th Apr 202311:26 amRNSNotice of First Quarter 2023 Results
12th Apr 202311:04 amRNSBuyback programme: transactions 30 March -11 April
11th Apr 20237:00 amRNSFurther re Santander Mexico tender offer: results
31st Mar 20232:28 pmRNS2023 AGM - Resolutions
31st Mar 202312:11 pmRNSTotal Voting Rights
31st Mar 20237:35 amRNSSantander to confirm its targets for 2023 at AGM
30th Mar 202311:05 amRNSBuyback programme: transactions 23 - 29 March
23rd Mar 202311:40 amRNSDirector/PDMR Shareholding
23rd Mar 202310:22 amRNSBuyback programme: transactions 16 - 22 March
21st Mar 20231:04 pmRNSFurther re capital reduction
17th Mar 202312:21 pmRNSDirector/PDMR Shareholding
16th Mar 20235:16 pmRNSTotal Voting Rights
16th Mar 202311:18 amRNSCapital reduction (buy-back programme shares)
16th Mar 202311:09 amRNSBuyback programme: transactions 9 - 15 March
10th Mar 20239:55 amRNS2022 UK Annual Report
9th Mar 20234:27 pmRNSDirector/PDMR Shareholding
9th Mar 202311:39 amRNSBuyback programme: transactions 1 - 8 March
6th Mar 20233:02 pmRNSDirector/PDMR Shareholding
6th Mar 20232:59 pmRNSDirector/PDMR Shareholding
28th Feb 20235:27 pmRNSNotice of AGM
28th Feb 202312:23 pmRNSTotal Voting Rights
28th Feb 20239:51 amRNSInvestor Day: Group CFO presentation
28th Feb 20238:33 amRNSInvestor Day: Group CEO presentation
28th Feb 20238:05 amRNSInvestor Day: Executive chair presentation
28th Feb 20237:00 amRNSPayout policy, strategic plans & profit forecasts
28th Feb 20237:00 amRNSExecution of 2022 shareholder remuneration policy
24th Feb 20237:00 amRNSDirector/PDMR Shareholding
21st Feb 202310:58 amRNSInvestor Day meeting announcement
17th Feb 20231:33 pmRNSDirector/PDMR Shareholding
7th Feb 202311:24 amRNSTender Offer
2nd Feb 20237:00 amRNS2022 Financial report & Earnings presentation
2nd Feb 20237:00 amRNS2022 Results - Press release
1st Feb 202311:06 amRNSEnd of the Programme & 26 -31 Jan Transactions
31st Jan 20233:22 pmRNSTotal Voting Rights
26th Jan 202311:08 amRNSNotice of 2022 Results
26th Jan 202311:03 amRNSBuyback programme: transactions 19 - 25 January
19th Jan 202311:14 amRNSBuyback programme: transactions 12 - 18 January
12th Jan 202311:29 amRNSBuyback programme: transactions 5 - 11 January
5th Jan 202311:14 amRNSBuyback programme: transactions 29 Dec- 4 Jan
30th Dec 202212:18 pmRNSTotal Voting Rights
29th Dec 202211:06 amRNSBuyback programme: transactions 21- 28 December
28th Dec 20227:00 amRNSTotal Voting Rights
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 202211:33 amRNSTotal early redemption of mortgage covered bonds
22nd Dec 202210:17 amRNSSREP Capital Requirements 2023
21st Dec 20224:59 pmRNSDirector/PDMR Shareholding
21st Dec 202211:14 amRNSBuyback programme: transactions 12- 20 December

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.